Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.193EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.193EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BL.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.163EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.3 (Theta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.3 (Theta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAVEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.17 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.17 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.25.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.409EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.83EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.310EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.362.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.144EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.144EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.288EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.288EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.249EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.378EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.97EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used